

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | signal peptide processing (GO:0006465) | 6.71352905 |
| 2 | behavioral response to nicotine (GO:0035095) | 6.46984507 |
| 3 | Golgi transport vesicle coating (GO:0048200) | 5.91875470 |
| 4 | COPI coating of Golgi vesicle (GO:0048205) | 5.91875470 |
| 5 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.99298234 |
| 6 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.89435511 |
| 7 | protein retention in ER lumen (GO:0006621) | 4.67917994 |
| 8 | protein maturation by protein folding (GO:0022417) | 4.40651747 |
| 9 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 4.23020564 |
| 10 | COPII vesicle coating (GO:0048208) | 4.16396221 |
| 11 | magnesium ion transport (GO:0015693) | 4.09792192 |
| 12 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 4.02923883 |
| 13 | gamma-aminobutyric acid transport (GO:0015812) | 3.94850835 |
| 14 | fucose catabolic process (GO:0019317) | 3.87709178 |
| 15 | L-fucose metabolic process (GO:0042354) | 3.87709178 |
| 16 | L-fucose catabolic process (GO:0042355) | 3.87709178 |
| 17 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.85957960 |
| 18 | peptide hormone processing (GO:0016486) | 3.80762782 |
| 19 | serotonin metabolic process (GO:0042428) | 3.77105143 |
| 20 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.71326505 |
| 21 | primary amino compound metabolic process (GO:1901160) | 3.69610214 |
| 22 | sulfation (GO:0051923) | 3.57905931 |
| 23 | neuronal action potential (GO:0019228) | 3.45549417 |
| 24 | endocrine pancreas development (GO:0031018) | 3.44648122 |
| 25 | nucleotide transmembrane transport (GO:1901679) | 3.44259199 |
| 26 | cellular response to ATP (GO:0071318) | 3.43920484 |
| 27 | ER overload response (GO:0006983) | 3.43824844 |
| 28 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.41643912 |
| 29 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.40859911 |
| 30 | central nervous system myelination (GO:0022010) | 3.31207763 |
| 31 | axon ensheathment in central nervous system (GO:0032291) | 3.31207763 |
| 32 | sphingosine metabolic process (GO:0006670) | 3.26292264 |
| 33 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 3.26186636 |
| 34 | membrane depolarization during action potential (GO:0086010) | 3.25226538 |
| 35 | indolalkylamine metabolic process (GO:0006586) | 3.24383886 |
| 36 | kynurenine metabolic process (GO:0070189) | 3.23352742 |
| 37 | sequestering of metal ion (GO:0051238) | 3.21779329 |
| 38 | somite development (GO:0061053) | 3.19056750 |
| 39 | indolalkylamine catabolic process (GO:0046218) | 3.12254827 |
| 40 | tryptophan catabolic process (GO:0006569) | 3.12254827 |
| 41 | indole-containing compound catabolic process (GO:0042436) | 3.12254827 |
| 42 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.12130739 |
| 43 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.10977189 |
| 44 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.08785518 |
| 45 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.07335292 |
| 46 | indole-containing compound metabolic process (GO:0042430) | 3.06297092 |
| 47 | glandular epithelial cell differentiation (GO:0002067) | 3.05879546 |
| 48 | positive regulation of fatty acid oxidation (GO:0046321) | 3.05069531 |
| 49 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.00962145 |
| 50 | startle response (GO:0001964) | 2.99223337 |
| 51 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.98173392 |
| 52 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.97203546 |
| 53 | intracellular pH reduction (GO:0051452) | 2.96615625 |
| 54 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.94529445 |
| 55 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.93530720 |
| 56 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.90082325 |
| 57 | L-phenylalanine catabolic process (GO:0006559) | 2.90082325 |
| 58 | copper ion homeostasis (GO:0055070) | 2.89095570 |
| 59 | cell proliferation in forebrain (GO:0021846) | 2.88181304 |
| 60 | GDP-mannose metabolic process (GO:0019673) | 2.87717007 |
| 61 | action potential (GO:0001508) | 2.86471174 |
| 62 | response to redox state (GO:0051775) | 2.86272860 |
| 63 | detection of light stimulus involved in visual perception (GO:0050908) | 2.85282859 |
| 64 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.85282859 |
| 65 | positive regulation of mitochondrial fission (GO:0090141) | 2.85017648 |
| 66 | pH reduction (GO:0045851) | 2.84684237 |
| 67 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.82755200 |
| 68 | cell redox homeostasis (GO:0045454) | 2.80361355 |
| 69 | diol metabolic process (GO:0034311) | 2.80109208 |
| 70 | membrane repolarization during action potential (GO:0086011) | 2.78742916 |
| 71 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.77802469 |
| 72 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.77408499 |
| 73 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 2.77337317 |
| 74 | nephron epithelium morphogenesis (GO:0072088) | 2.77044461 |
| 75 | nephron tubule morphogenesis (GO:0072078) | 2.77044461 |
| 76 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.76592360 |
| 77 | cysteine metabolic process (GO:0006534) | 2.76350256 |
| 78 | synaptic transmission, cholinergic (GO:0007271) | 2.75164011 |
| 79 | adhesion of symbiont to host cell (GO:0044650) | 2.74630197 |
| 80 | virion attachment to host cell (GO:0019062) | 2.74630197 |
| 81 | neuronal action potential propagation (GO:0019227) | 2.73518329 |
| 82 | membrane budding (GO:0006900) | 2.72741485 |
| 83 | regulation of action potential (GO:0098900) | 2.72379253 |
| 84 | tryptophan metabolic process (GO:0006568) | 2.71938240 |
| 85 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.71850033 |
| 86 | toxin metabolic process (GO:0009404) | 2.71768840 |
| 87 | type B pancreatic cell development (GO:0003323) | 2.71381990 |
| 88 | transmission of nerve impulse (GO:0019226) | 2.71339346 |
| 89 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.70832651 |
| 90 | spinal cord motor neuron differentiation (GO:0021522) | 2.69893053 |
| 91 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.68636802 |
| 92 | regulation of hippo signaling (GO:0035330) | 2.68444107 |
| 93 | cAMP catabolic process (GO:0006198) | 2.68079250 |
| 94 | postsynaptic membrane organization (GO:0001941) | 2.67431030 |
| 95 | localization within membrane (GO:0051668) | 2.66877410 |
| 96 | regulation of metalloenzyme activity (GO:0048552) | 2.66721302 |
| 97 | regulation of energy homeostasis (GO:2000505) | 2.66290070 |
| 98 | glycosylceramide metabolic process (GO:0006677) | 2.66192320 |
| 99 | regulation of membrane repolarization (GO:0060306) | 2.65447898 |
| 100 | cellular copper ion homeostasis (GO:0006878) | 2.64995535 |
| 101 | DNA deamination (GO:0045006) | 2.64895112 |
| 102 | nucleotide transport (GO:0006862) | 2.64268830 |
| 103 | regulation of glucocorticoid metabolic process (GO:0031943) | 2.63190108 |
| 104 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.61324747 |
| 105 | L-phenylalanine metabolic process (GO:0006558) | 2.61324747 |
| 106 | cellular ketone body metabolic process (GO:0046950) | 2.61081696 |
| 107 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.61027585 |
| 108 | positive regulation of autophagy (GO:0010508) | 2.60935050 |
| 109 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.60781317 |
| 110 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.60781317 |
| 111 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.60583219 |
| 112 | autophagic vacuole fusion (GO:0000046) | 2.60363890 |
| 113 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.59817901 |
| 114 | sphingoid metabolic process (GO:0046519) | 2.58786363 |
| 115 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.57573872 |
| 116 | regulation of mesoderm development (GO:2000380) | 2.57252914 |
| 117 | positive regulation of insulin secretion (GO:0032024) | 2.57163720 |
| 118 | eye photoreceptor cell differentiation (GO:0001754) | 2.56130135 |
| 119 | photoreceptor cell differentiation (GO:0046530) | 2.56130135 |
| 120 | nucleotide-sugar metabolic process (GO:0009225) | 2.55855601 |
| 121 | response to pheromone (GO:0019236) | 2.55593785 |
| 122 | peptidyl-asparagine modification (GO:0018196) | 2.53706493 |
| 123 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.53517315 |
| 124 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.53517315 |
| 125 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.52644018 |
| 126 | peristalsis (GO:0030432) | 2.52570499 |
| 127 | autophagic vacuole assembly (GO:0000045) | 2.52428629 |
| 128 | response to misfolded protein (GO:0051788) | 2.51966604 |
| 129 | regulation of sequestering of triglyceride (GO:0010889) | 2.51531124 |
| 130 | peptide metabolic process (GO:0006518) | 2.51438783 |
| 131 | neurotransmitter metabolic process (GO:0042133) | 2.51424086 |
| 132 | nucleoside diphosphate catabolic process (GO:0009134) | 2.50640936 |
| 133 | regulation of neurotransmitter uptake (GO:0051580) | 2.49756084 |
| 134 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.49188424 |
| 135 | vesicle fusion (GO:0006906) | 2.47924732 |
| 136 | parturition (GO:0007567) | 2.45945948 |
| 137 | protein polyglutamylation (GO:0018095) | 2.45896770 |
| 138 | negative regulation of mast cell activation (GO:0033004) | 2.45599151 |
| 139 | neuromuscular synaptic transmission (GO:0007274) | 2.45405629 |
| 140 | protein localization to synapse (GO:0035418) | 2.44521637 |
| 141 | negative regulation of astrocyte differentiation (GO:0048712) | 2.44076785 |
| 142 | epithelial cilium movement (GO:0003351) | 2.43837785 |
| 143 | protein N-linked glycosylation (GO:0006487) | 2.43711968 |
| 144 | fatty acid elongation (GO:0030497) | 2.43709083 |
| 145 | positive regulation of action potential (GO:0045760) | 2.43439679 |
| 146 | glycolipid catabolic process (GO:0019377) | 2.43376617 |
| 147 | cornea development in camera-type eye (GO:0061303) | 2.42904539 |
| 148 | dopamine transport (GO:0015872) | 2.42836461 |
| 149 | reflex (GO:0060004) | 2.42445968 |
| 150 | regulation of protein glycosylation (GO:0060049) | 2.42268825 |
| 151 | interkinetic nuclear migration (GO:0022027) | 2.42095497 |
| 152 | cyclic nucleotide catabolic process (GO:0009214) | 2.41680854 |
| 153 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.41100687 |
| 154 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.40630693 |
| 155 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.40079056 |
| 156 | urinary tract smooth muscle contraction (GO:0014848) | 2.38913290 |
| 157 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.38530784 |
| 158 | glycosphingolipid catabolic process (GO:0046479) | 2.38112568 |
| 159 | kidney morphogenesis (GO:0060993) | 2.37733263 |
| 160 | synaptic transmission, glutamatergic (GO:0035249) | 2.37439895 |
| 161 | dopamine biosynthetic process (GO:0042416) | 2.37428801 |
| 162 | response to hydroperoxide (GO:0033194) | 2.36137943 |
| 163 | behavioral fear response (GO:0001662) | 2.35813977 |
| 164 | behavioral defense response (GO:0002209) | 2.35813977 |
| 165 | neural tube formation (GO:0001841) | 2.35545833 |
| 166 | negative regulation of telomere maintenance (GO:0032205) | 2.35410243 |
| 167 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.35389081 |
| 168 | response to dietary excess (GO:0002021) | 2.35081780 |
| 169 | protein import into peroxisome matrix (GO:0016558) | 2.34868487 |
| 170 | protein localization to cilium (GO:0061512) | 2.34766365 |
| 171 | tissue regeneration (GO:0042246) | 2.34520935 |
| 172 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.34228243 |
| 173 | fear response (GO:0042596) | 2.33632778 |
| 174 | dendritic spine morphogenesis (GO:0060997) | 2.31822201 |
| 175 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.30796188 |
| 176 | cardiovascular system development (GO:0072358) | 2.30623743 |
| 177 | endoderm formation (GO:0001706) | 2.30539852 |
| 178 | vesicle coating (GO:0006901) | 2.30529548 |
| 179 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.30520949 |
| 180 | glutamate receptor signaling pathway (GO:0007215) | 2.30035727 |
| 181 | GPI anchor biosynthetic process (GO:0006506) | 2.29830110 |
| 182 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.29125482 |
| 183 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.29067564 |
| 184 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.28964625 |
| 185 | creatine metabolic process (GO:0006600) | 2.27746605 |
| 186 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.27291701 |
| 187 | exocrine pancreas development (GO:0031017) | 2.27251095 |
| 188 | organelle membrane fusion (GO:0090174) | 2.26876434 |
| 189 | Golgi organization (GO:0007030) | 2.26357977 |
| 190 | protein localization to endosome (GO:0036010) | 2.25626277 |
| 191 | mitochondrial calcium ion transport (GO:0006851) | 2.24865218 |
| 192 | cellular response to leptin stimulus (GO:0044320) | 2.24402217 |
| 193 | autophagy (GO:0006914) | 2.22839014 |
| 194 | positive regulation of transforming growth factor beta production (GO:0071636) | 2.19212379 |
| 195 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.18802668 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.34284451 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.72409406 |
| 3 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.85745600 |
| 4 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.44837008 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.20284041 |
| 6 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.86868471 |
| 7 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.82252363 |
| 8 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.41495340 |
| 9 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.38657147 |
| 10 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.30892394 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.20164999 |
| 12 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.13787395 |
| 13 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.08470587 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.08229295 |
| 15 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.07572591 |
| 16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.05927880 |
| 17 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.05278950 |
| 18 | VDR_22108803_ChIP-Seq_LS180_Human | 2.02612227 |
| 19 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.01630748 |
| 20 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.00912470 |
| 21 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.98201148 |
| 22 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.96769743 |
| 23 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.96531375 |
| 24 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.96509378 |
| 25 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.93957509 |
| 26 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.93665105 |
| 27 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.93476266 |
| 28 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.92578354 |
| 29 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.92332297 |
| 30 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.91504940 |
| 31 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.89999553 |
| 32 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.89999553 |
| 33 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.87771538 |
| 34 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.83037733 |
| 35 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.80370206 |
| 36 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.78534141 |
| 37 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.77400929 |
| 38 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.75967363 |
| 39 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.73196881 |
| 40 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.72106706 |
| 41 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.66104168 |
| 42 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.64907818 |
| 43 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.64807660 |
| 44 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.63874043 |
| 45 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.62803246 |
| 46 | P300_19829295_ChIP-Seq_ESCs_Human | 1.62030322 |
| 47 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.60069122 |
| 48 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.58940112 |
| 49 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.58219118 |
| 50 | FUS_26573619_Chip-Seq_HEK293_Human | 1.57866905 |
| 51 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.57192860 |
| 52 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.57008146 |
| 53 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.55043844 |
| 54 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.52620921 |
| 55 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.52495204 |
| 56 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.51567163 |
| 57 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.51330602 |
| 58 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.51330602 |
| 59 | EWS_26573619_Chip-Seq_HEK293_Human | 1.50472472 |
| 60 | STAT3_23295773_ChIP-Seq_U87_Human | 1.49725205 |
| 61 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.48696740 |
| 62 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.48219668 |
| 63 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.46635538 |
| 64 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.46361345 |
| 65 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.45247783 |
| 66 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.43865684 |
| 67 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.42882516 |
| 68 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.42652184 |
| 69 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.40793421 |
| 70 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.39028923 |
| 71 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.37367103 |
| 72 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.37183328 |
| 73 | TCF4_23295773_ChIP-Seq_U87_Human | 1.36826351 |
| 74 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.36409623 |
| 75 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.36195063 |
| 76 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.35974842 |
| 77 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.34788781 |
| 78 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.34625577 |
| 79 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.34233226 |
| 80 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.31265081 |
| 81 | AR_25329375_ChIP-Seq_VCAP_Human | 1.30790452 |
| 82 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.29835606 |
| 83 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.29686209 |
| 84 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.29637509 |
| 85 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.29213302 |
| 86 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.28968389 |
| 87 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.27976104 |
| 88 | TP53_16413492_ChIP-PET_HCT116_Human | 1.27623567 |
| 89 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.26454665 |
| 90 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.26157540 |
| 91 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.25864105 |
| 92 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.25130682 |
| 93 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.24240654 |
| 94 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.24240654 |
| 95 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.23879112 |
| 96 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.23874327 |
| 97 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.21789241 |
| 98 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.21127190 |
| 99 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.20956241 |
| 100 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.20690194 |
| 101 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.20613351 |
| 102 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.19494127 |
| 103 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.19333809 |
| 104 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.18230318 |
| 105 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.17890933 |
| 106 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.17237946 |
| 107 | GATA1_22025678_ChIP-Seq_K562_Human | 1.16169374 |
| 108 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.16049216 |
| 109 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.15605921 |
| 110 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.13496705 |
| 111 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.12849279 |
| 112 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.12231029 |
| 113 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.11918374 |
| 114 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.11733633 |
| 115 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.10858190 |
| 116 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.10769337 |
| 117 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.10005626 |
| 118 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.09510365 |
| 119 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.09256935 |
| 120 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.09216835 |
| 121 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.08947079 |
| 122 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.08780988 |
| 123 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.07803958 |
| 124 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.06971437 |
| 125 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.06277990 |
| 126 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.05490078 |
| 127 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.05376235 |
| 128 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.04981328 |
| 129 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.04746908 |
| 130 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.04746908 |
| 131 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.04396312 |
| 132 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.03949807 |
| 133 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.03486252 |
| 134 | * ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.02959879 |
| 135 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.02756465 |
| 136 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.02236307 |
| 137 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.02236307 |
| 138 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.02220716 |
| 139 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.01704049 |
| 140 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.01523064 |
| 141 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.01263862 |
| 142 | * FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.01056236 |
| 143 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.00680485 |
| 144 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.00674131 |
| 145 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.00650554 |
| 146 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.99969859 |
| 147 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.99770720 |
| 148 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.99251377 |
| 149 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.99087894 |
| 150 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.98351365 |
| 151 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.98189467 |
| 152 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.97292433 |
| 153 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.97292433 |
| 154 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.97265873 |
| 155 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.97210157 |
| 156 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96685895 |
| 157 | * GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.96383891 |
| 158 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.96130910 |
| 159 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.95279613 |
| 160 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.95273968 |
| 161 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.95086104 |
| 162 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.94561876 |
| 163 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.93506560 |
| 164 | GATA3_26560356_Chip-Seq_TH2_Human | 0.93489831 |
| 165 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.93377524 |
| 166 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92953263 |
| 167 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.92479152 |
| 168 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.92090602 |
| 169 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.91235127 |
| 170 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.91115203 |
| 171 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.90803356 |
| 172 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.90291187 |
| 173 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.90233885 |
| 174 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.88248697 |
| 175 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.87754977 |
| 176 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.85849102 |
| 177 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.85427320 |
| 178 | * TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.84203048 |
| 179 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84119921 |
| 180 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83443754 |
| 181 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.83201059 |
| 182 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.82194192 |
| 183 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.81610158 |
| 184 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.79585370 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003195_calcinosis | 4.21850950 |
| 2 | MP0000013_abnormal_adipose_tissue | 4.02249150 |
| 3 | MP0002009_preneoplasia | 3.38471872 |
| 4 | MP0003183_abnormal_peptide_metabolism | 3.28388559 |
| 5 | MP0002877_abnormal_melanocyte_morpholog | 3.15764747 |
| 6 | MP0008260_abnormal_autophagy | 3.09087544 |
| 7 | MP0010386_abnormal_urinary_bladder | 2.83487522 |
| 8 | MP0000569_abnormal_digit_pigmentation | 2.81227455 |
| 9 | MP0003646_muscle_fatigue | 2.74292459 |
| 10 | MP0009046_muscle_twitch | 2.66440005 |
| 11 | MP0004043_abnormal_pH_regulation | 2.64697540 |
| 12 | MP0009780_abnormal_chondrocyte_physiolo | 2.44980857 |
| 13 | MP0009745_abnormal_behavioral_response | 2.43557345 |
| 14 | MP0005058_abnormal_lysosome_morphology | 2.33392915 |
| 15 | MP0003656_abnormal_erythrocyte_physiolo | 2.22805152 |
| 16 | MP0002272_abnormal_nervous_system | 2.22755946 |
| 17 | MP0005310_abnormal_salivary_gland | 2.22349667 |
| 18 | MP0003787_abnormal_imprinting | 2.19694336 |
| 19 | MP0005379_endocrine/exocrine_gland_phen | 2.19614155 |
| 20 | MP0001968_abnormal_touch/_nociception | 2.18846699 |
| 21 | MP0002064_seizures | 2.16924765 |
| 22 | MP0002693_abnormal_pancreas_physiology | 2.13579185 |
| 23 | MP0005551_abnormal_eye_electrophysiolog | 2.11550768 |
| 24 | MP0005646_abnormal_pituitary_gland | 2.10282003 |
| 25 | MP0001944_abnormal_pancreas_morphology | 2.07908650 |
| 26 | MP0001485_abnormal_pinna_reflex | 2.02553775 |
| 27 | MP0006292_abnormal_olfactory_placode | 2.01284982 |
| 28 | MP0003635_abnormal_synaptic_transmissio | 1.97830373 |
| 29 | MP0001661_extended_life_span | 1.96054475 |
| 30 | MP0005408_hypopigmentation | 1.95355149 |
| 31 | MP0005220_abnormal_exocrine_pancreas | 1.90209782 |
| 32 | MP0006054_spinal_hemorrhage | 1.88275390 |
| 33 | MP0003329_amyloid_beta_deposits | 1.85964071 |
| 34 | MP0004133_heterotaxia | 1.84994553 |
| 35 | MP0003724_increased_susceptibility_to | 1.83585228 |
| 36 | MP0002909_abnormal_adrenal_gland | 1.82122590 |
| 37 | MP0001542_abnormal_bone_strength | 1.81547359 |
| 38 | MP0002102_abnormal_ear_morphology | 1.81367493 |
| 39 | MP0002160_abnormal_reproductive_system | 1.79325725 |
| 40 | MP0005636_abnormal_mineral_homeostasis | 1.78989146 |
| 41 | MP0004142_abnormal_muscle_tone | 1.78219987 |
| 42 | MP0010234_abnormal_vibrissa_follicle | 1.77612100 |
| 43 | MP0002735_abnormal_chemical_nociception | 1.74735076 |
| 44 | MP0002063_abnormal_learning/memory/cond | 1.73533985 |
| 45 | MP0008877_abnormal_DNA_methylation | 1.71461655 |
| 46 | MP0002139_abnormal_hepatobiliary_system | 1.70926178 |
| 47 | MP0000631_abnormal_neuroendocrine_gland | 1.70178602 |
| 48 | MP0008872_abnormal_physiological_respon | 1.70097934 |
| 49 | MP0009643_abnormal_urine_homeostasis | 1.69790632 |
| 50 | MP0005332_abnormal_amino_acid | 1.68858069 |
| 51 | MP0001486_abnormal_startle_reflex | 1.67080418 |
| 52 | MP0004147_increased_porphyrin_level | 1.66421590 |
| 53 | MP0003806_abnormal_nucleotide_metabolis | 1.65332156 |
| 54 | MP0003880_abnormal_central_pattern | 1.65269381 |
| 55 | MP0003186_abnormal_redox_activity | 1.64840067 |
| 56 | MP0001756_abnormal_urination | 1.64171127 |
| 57 | MP0002572_abnormal_emotion/affect_behav | 1.62983861 |
| 58 | MP0002876_abnormal_thyroid_physiology | 1.59686429 |
| 59 | MP0002166_altered_tumor_susceptibility | 1.58790334 |
| 60 | MP0002733_abnormal_thermal_nociception | 1.57110702 |
| 61 | MP0001765_abnormal_ion_homeostasis | 1.57044373 |
| 62 | MP0004185_abnormal_adipocyte_glucose | 1.56490698 |
| 63 | MP0003879_abnormal_hair_cell | 1.50217060 |
| 64 | MP0002138_abnormal_hepatobiliary_system | 1.48013241 |
| 65 | MP0005451_abnormal_body_composition | 1.47590716 |
| 66 | MP0002067_abnormal_sensory_capabilities | 1.46901147 |
| 67 | MP0002653_abnormal_ependyma_morphology | 1.46623560 |
| 68 | MP0000604_amyloidosis | 1.46562623 |
| 69 | MP0002736_abnormal_nociception_after | 1.46219071 |
| 70 | MP0000003_abnormal_adipose_tissue | 1.45498281 |
| 71 | MP0001970_abnormal_pain_threshold | 1.45272403 |
| 72 | MP0001502_abnormal_circadian_rhythm | 1.44735346 |
| 73 | MP0000920_abnormal_myelination | 1.43653635 |
| 74 | MP0005423_abnormal_somatic_nervous | 1.42615438 |
| 75 | MP0002557_abnormal_social/conspecific_i | 1.41687231 |
| 76 | MP0001501_abnormal_sleep_pattern | 1.40984696 |
| 77 | MP0000613_abnormal_salivary_gland | 1.39530923 |
| 78 | MP0004145_abnormal_muscle_electrophysio | 1.39479047 |
| 79 | MP0003718_maternal_effect | 1.38123236 |
| 80 | MP0002078_abnormal_glucose_homeostasis | 1.37063669 |
| 81 | MP0000049_abnormal_middle_ear | 1.36449821 |
| 82 | MP0000778_abnormal_nervous_system | 1.36359324 |
| 83 | MP0008438_abnormal_cutaneous_collagen | 1.36063836 |
| 84 | MP0005389_reproductive_system_phenotype | 1.33455906 |
| 85 | MP0000230_abnormal_systemic_arterial | 1.31249693 |
| 86 | MP0004924_abnormal_behavior | 1.31064028 |
| 87 | MP0005386_behavior/neurological_phenoty | 1.31064028 |
| 88 | MP0004859_abnormal_synaptic_plasticity | 1.30510732 |
| 89 | MP0002234_abnormal_pharynx_morphology | 1.29379848 |
| 90 | MP0002734_abnormal_mechanical_nocicepti | 1.29349267 |
| 91 | MP0009384_cardiac_valve_regurgitation | 1.28976268 |
| 92 | MP0000427_abnormal_hair_cycle | 1.27747539 |
| 93 | MP0004742_abnormal_vestibular_system | 1.25420960 |
| 94 | MP0001440_abnormal_grooming_behavior | 1.23484620 |
| 95 | MP0005084_abnormal_gallbladder_morpholo | 1.23194628 |
| 96 | MP0001881_abnormal_mammary_gland | 1.23149824 |
| 97 | MP0005174_abnormal_tail_pigmentation | 1.23000591 |
| 98 | MP0005645_abnormal_hypothalamus_physiol | 1.22290170 |
| 99 | MP0000639_abnormal_adrenal_gland | 1.21293559 |
| 100 | MP0003136_yellow_coat_color | 1.21170480 |
| 101 | MP0000955_abnormal_spinal_cord | 1.20235154 |
| 102 | MP0002837_dystrophic_cardiac_calcinosis | 1.19242477 |
| 103 | MP0004782_abnormal_surfactant_physiolog | 1.18325849 |
| 104 | MP0006072_abnormal_retinal_apoptosis | 1.16571660 |
| 105 | MP0005365_abnormal_bile_salt | 1.16053942 |
| 106 | MP0005253_abnormal_eye_physiology | 1.15586051 |
| 107 | MP0005275_abnormal_skin_tensile | 1.15364429 |
| 108 | MP0008875_abnormal_xenobiotic_pharmacok | 1.14410028 |
| 109 | MP0005535_abnormal_body_temperature | 1.12320445 |
| 110 | MP0003119_abnormal_digestive_system | 1.12230653 |
| 111 | MP0003938_abnormal_ear_development | 1.12130931 |
| 112 | MP0000026_abnormal_inner_ear | 1.10204802 |
| 113 | MP0006036_abnormal_mitochondrial_physio | 1.09399667 |
| 114 | MP0003011_delayed_dark_adaptation | 1.09035273 |
| 115 | MP0002752_abnormal_somatic_nervous | 1.06688968 |
| 116 | MP0002882_abnormal_neuron_morphology | 1.06239565 |
| 117 | MP0002971_abnormal_brown_adipose | 1.05670027 |
| 118 | MP0002928_abnormal_bile_duct | 1.05425276 |
| 119 | MP0002184_abnormal_innervation | 1.04898411 |
| 120 | MP0001533_abnormal_skeleton_physiology | 1.04083565 |
| 121 | MP0005195_abnormal_posterior_eye | 1.03695268 |
| 122 | MP0001963_abnormal_hearing_physiology | 1.02715634 |
| 123 | MP0004215_abnormal_myocardial_fiber | 1.00017858 |
| 124 | MP0005164_abnormal_response_to | 0.98699319 |
| 125 | MP0005375_adipose_tissue_phenotype | 0.98464823 |
| 126 | MP0002118_abnormal_lipid_homeostasis | 0.97755665 |
| 127 | MP0003300_gastrointestinal_ulcer | 0.97479436 |
| 128 | MP0003633_abnormal_nervous_system | 0.96299376 |
| 129 | MP0001919_abnormal_reproductive_system | 0.95987492 |
| 130 | MP0002229_neurodegeneration | 0.95388058 |
| 131 | MP0000383_abnormal_hair_follicle | 0.95201937 |
| 132 | MP0003890_abnormal_embryonic-extraembry | 0.93280541 |
| 133 | MP0003795_abnormal_bone_structure | 0.93108289 |
| 134 | MP0002006_tumorigenesis | 0.92462438 |
| 135 | MP0001764_abnormal_homeostasis | 0.92276458 |
| 136 | MP0009840_abnormal_foam_cell | 0.92249331 |
| 137 | MP0000538_abnormal_urinary_bladder | 0.91393151 |
| 138 | MP0003868_abnormal_feces_composition | 0.90628133 |
| 139 | MP0002277_abnormal_respiratory_mucosa | 0.90479302 |
| 140 | MP0003283_abnormal_digestive_organ | 0.89680099 |
| 141 | MP0000681_abnormal_thyroid_gland | 0.88796720 |
| 142 | MP0002938_white_spotting | 0.88237487 |
| 143 | MP0003632_abnormal_nervous_system | 0.86520298 |
| 144 | MP0003631_nervous_system_phenotype | 0.86442913 |
| 145 | MP0001346_abnormal_lacrimal_gland | 0.85100476 |
| 146 | MP0003937_abnormal_limbs/digits/tail_de | 0.84861717 |
| 147 | MP0003137_abnormal_impulse_conducting | 0.84554004 |
| 148 | MP0002933_joint_inflammation | 0.84486919 |
| 149 | MP0004885_abnormal_endolymph | 0.83889179 |
| 150 | MP0001986_abnormal_taste_sensitivity | 0.83439397 |
| 151 | MP0008775_abnormal_heart_ventricle | 0.82475406 |
| 152 | MP0001666_abnormal_nutrient_absorption | 0.82469589 |
| 153 | MP0003959_abnormal_lean_body | 0.81927903 |
| 154 | MP0001851_eye_inflammation | 0.81047629 |
| 155 | MP0000609_abnormal_liver_physiology | 0.80950377 |
| 156 | MP0006082_CNS_inflammation | 0.79787813 |
| 157 | MP0001664_abnormal_digestion | 0.79671332 |
| 158 | MP0002638_abnormal_pupillary_reflex | 0.79278702 |
| 159 | MP0002163_abnormal_gland_morphology | 0.79082812 |
| 160 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.78835555 |
| 161 | MP0003221_abnormal_cardiomyocyte_apopto | 0.77957893 |
| 162 | MP0004270_analgesia | 0.77697177 |
| 163 | MP0002066_abnormal_motor_capabilities/c | 0.77633367 |
| 164 | MP0002822_catalepsy | 0.77341359 |
| 165 | MP0006276_abnormal_autonomic_nervous | 0.76450627 |
| 166 | MP0005360_urolithiasis | 0.76239793 |
| 167 | MP0005666_abnormal_adipose_tissue | 0.74767494 |
| 168 | MP0005448_abnormal_energy_balance | 0.73772665 |
| 169 | MP0001299_abnormal_eye_distance/ | 0.72625494 |
| 170 | MP0003950_abnormal_plasma_membrane | 0.72581650 |
| 171 | MP0005377_hearing/vestibular/ear_phenot | 0.71880704 |
| 172 | MP0005395_other_phenotype | 0.69619491 |
| 173 | MP0003953_abnormal_hormone_level | 0.68453612 |
| 174 | MP0009785_altered_susceptibility_to | 0.66926860 |
| 175 | MP0001905_abnormal_dopamine_level | 0.66850785 |
| 176 | MP0004130_abnormal_muscle_cell | 0.63446885 |
| 177 | MP0008469_abnormal_protein_level | 0.63318072 |
| 178 | MP0004272_abnormal_basement_membrane | 0.62316961 |
| 179 | MP0002998_abnormal_bone_remodeling | 0.61799003 |
| 180 | MP0009333_abnormal_splenocyte_physiolog | 0.61705553 |
| 181 | MP0004264_abnormal_extraembryonic_tissu | 0.61062460 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic coma (HP:0001325) | 4.45544333 |
| 2 | Pancreatic cysts (HP:0001737) | 4.35044465 |
| 3 | Hypoglycemic seizures (HP:0002173) | 4.13923326 |
| 4 | Pancreatic fibrosis (HP:0100732) | 3.97235248 |
| 5 | Molar tooth sign on MRI (HP:0002419) | 3.95392888 |
| 6 | Abnormality of midbrain morphology (HP:0002418) | 3.95392888 |
| 7 | Genetic anticipation (HP:0003743) | 3.89976123 |
| 8 | Hyperventilation (HP:0002883) | 3.78137041 |
| 9 | True hermaphroditism (HP:0010459) | 3.76320372 |
| 10 | Nephronophthisis (HP:0000090) | 3.64489510 |
| 11 | Congenital stationary night blindness (HP:0007642) | 3.62666265 |
| 12 | Progressive cerebellar ataxia (HP:0002073) | 3.62578272 |
| 13 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.61572694 |
| 14 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.56364826 |
| 15 | Symptomatic seizures (HP:0011145) | 3.44356293 |
| 16 | Progressive neurologic deterioration (HP:0002344) | 3.19437021 |
| 17 | Type II lissencephaly (HP:0007260) | 3.15860884 |
| 18 | Abnormal drinking behavior (HP:0030082) | 3.11278061 |
| 19 | Polydipsia (HP:0001959) | 3.11278061 |
| 20 | Clumsiness (HP:0002312) | 3.11007322 |
| 21 | Abnormality of the renal medulla (HP:0100957) | 3.08254429 |
| 22 | Hypothermia (HP:0002045) | 3.07358898 |
| 23 | Protruding tongue (HP:0010808) | 3.00676858 |
| 24 | Generalized aminoaciduria (HP:0002909) | 2.94776512 |
| 25 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.91839763 |
| 26 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.89606277 |
| 27 | Febrile seizures (HP:0002373) | 2.89541619 |
| 28 | Gaze-evoked nystagmus (HP:0000640) | 2.87493720 |
| 29 | Gout (HP:0001997) | 2.84427733 |
| 30 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.80634992 |
| 31 | Cystic liver disease (HP:0006706) | 2.74882250 |
| 32 | Hyperglycemia (HP:0003074) | 2.72936857 |
| 33 | Dysautonomia (HP:0002459) | 2.70809293 |
| 34 | Ketoacidosis (HP:0001993) | 2.70398781 |
| 35 | Dysostosis multiplex (HP:0000943) | 2.67294744 |
| 36 | Abnormality of the renal cortex (HP:0011035) | 2.65821876 |
| 37 | Pheochromocytoma (HP:0002666) | 2.65520080 |
| 38 | Decreased circulating renin level (HP:0003351) | 2.64805463 |
| 39 | Chorioretinal atrophy (HP:0000533) | 2.63828212 |
| 40 | Broad-based gait (HP:0002136) | 2.63693847 |
| 41 | Vacuolated lymphocytes (HP:0001922) | 2.63575404 |
| 42 | Inability to walk (HP:0002540) | 2.62880922 |
| 43 | Focal seizures (HP:0007359) | 2.62205424 |
| 44 | Absent/shortened dynein arms (HP:0200106) | 2.58555338 |
| 45 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.58555338 |
| 46 | Focal motor seizures (HP:0011153) | 2.58019399 |
| 47 | Abolished electroretinogram (ERG) (HP:0000550) | 2.56025026 |
| 48 | Neuroendocrine neoplasm (HP:0100634) | 2.55726974 |
| 49 | Pendular nystagmus (HP:0012043) | 2.55580696 |
| 50 | Thoracolumbar scoliosis (HP:0002944) | 2.52039312 |
| 51 | Abnormal protein glycosylation (HP:0012346) | 2.51661316 |
| 52 | Abnormal glycosylation (HP:0012345) | 2.51661316 |
| 53 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.51661316 |
| 54 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.51661316 |
| 55 | Large for gestational age (HP:0001520) | 2.51394745 |
| 56 | Medial flaring of the eyebrow (HP:0010747) | 2.48327675 |
| 57 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.47386718 |
| 58 | Chronic hepatic failure (HP:0100626) | 2.44149190 |
| 59 | Abnormality of the intrinsic pathway (HP:0010989) | 2.42873419 |
| 60 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.42155622 |
| 61 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.41111337 |
| 62 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.41111337 |
| 63 | Abnormality of glycolipid metabolism (HP:0010969) | 2.41111337 |
| 64 | Patellar aplasia (HP:0006443) | 2.39878224 |
| 65 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.39363842 |
| 66 | Sclerocornea (HP:0000647) | 2.39126918 |
| 67 | Neurofibrillary tangles (HP:0002185) | 2.37876881 |
| 68 | Tubular atrophy (HP:0000092) | 2.37849178 |
| 69 | Furrowed tongue (HP:0000221) | 2.35662149 |
| 70 | Cerebral hemorrhage (HP:0001342) | 2.33429018 |
| 71 | Hypokalemic alkalosis (HP:0001949) | 2.32248841 |
| 72 | Concave nail (HP:0001598) | 2.28521611 |
| 73 | Limb dystonia (HP:0002451) | 2.25239120 |
| 74 | Male pseudohermaphroditism (HP:0000037) | 2.24444508 |
| 75 | Spastic paraparesis (HP:0002313) | 2.23757065 |
| 76 | Polyuria (HP:0000103) | 2.22318220 |
| 77 | Attenuation of retinal blood vessels (HP:0007843) | 2.22176503 |
| 78 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.20565991 |
| 79 | Dialeptic seizures (HP:0011146) | 2.18722664 |
| 80 | Atonic seizures (HP:0010819) | 2.18171838 |
| 81 | Keratoconus (HP:0000563) | 2.17434465 |
| 82 | Increased corneal curvature (HP:0100692) | 2.17434465 |
| 83 | Tachypnea (HP:0002789) | 2.12902083 |
| 84 | Birth length less than 3rd percentile (HP:0003561) | 2.11852254 |
| 85 | Ketosis (HP:0001946) | 2.11247049 |
| 86 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.08917584 |
| 87 | Agitation (HP:0000713) | 2.07453849 |
| 88 | Stomach cancer (HP:0012126) | 2.06541931 |
| 89 | Brushfield spots (HP:0001088) | 2.06004876 |
| 90 | Severe muscular hypotonia (HP:0006829) | 2.05833913 |
| 91 | Progressive inability to walk (HP:0002505) | 2.05736673 |
| 92 | Congenital, generalized hypertrichosis (HP:0004540) | 2.05734016 |
| 93 | Type I transferrin isoform profile (HP:0003642) | 2.05569325 |
| 94 | Gait imbalance (HP:0002141) | 2.05005341 |
| 95 | Hypomagnesemia (HP:0002917) | 2.04969476 |
| 96 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.04920966 |
| 97 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.04920966 |
| 98 | Chronic bronchitis (HP:0004469) | 2.03309632 |
| 99 | Hepatic necrosis (HP:0002605) | 2.03032599 |
| 100 | Abnormality of the common coagulation pathway (HP:0010990) | 2.01295056 |
| 101 | Reduced antithrombin III activity (HP:0001976) | 2.00943713 |
| 102 | Abnormality of alanine metabolism (HP:0010916) | 2.00591557 |
| 103 | Hyperalaninemia (HP:0003348) | 2.00591557 |
| 104 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.00591557 |
| 105 | Irregular vertebral endplates (HP:0003301) | 2.00557997 |
| 106 | Epileptic encephalopathy (HP:0200134) | 2.00206074 |
| 107 | Acute encephalopathy (HP:0006846) | 1.99868235 |
| 108 | Hemiparesis (HP:0001269) | 1.99609694 |
| 109 | Congenital sensorineural hearing impairment (HP:0008527) | 1.99074822 |
| 110 | Anencephaly (HP:0002323) | 1.98604124 |
| 111 | Absence seizures (HP:0002121) | 1.98057583 |
| 112 | Congenital hepatic fibrosis (HP:0002612) | 1.97653442 |
| 113 | Decreased central vision (HP:0007663) | 1.97031418 |
| 114 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.96650752 |
| 115 | Visual hallucinations (HP:0002367) | 1.95673106 |
| 116 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.95480888 |
| 117 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.95480888 |
| 118 | Acute necrotizing encephalopathy (HP:0006965) | 1.95275709 |
| 119 | Increased cerebral lipofuscin (HP:0011813) | 1.94905187 |
| 120 | Irritability (HP:0000737) | 1.94620544 |
| 121 | Lissencephaly (HP:0001339) | 1.94558076 |
| 122 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.93513825 |
| 123 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.93426714 |
| 124 | Hyperactive renin-angiotensin system (HP:0000841) | 1.93388321 |
| 125 | Retinal atrophy (HP:0001105) | 1.92905524 |
| 126 | Mucopolysacchariduria (HP:0008155) | 1.92853473 |
| 127 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.92853473 |
| 128 | Cerebellar dysplasia (HP:0007033) | 1.92582280 |
| 129 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.92163683 |
| 130 | Abnormality of magnesium homeostasis (HP:0004921) | 1.91665581 |
| 131 | Microretrognathia (HP:0000308) | 1.90554065 |
| 132 | Glycosuria (HP:0003076) | 1.90490913 |
| 133 | Abnormality of urine glucose concentration (HP:0011016) | 1.90490913 |
| 134 | Glucose intolerance (HP:0000833) | 1.89977198 |
| 135 | Abnormality of binocular vision (HP:0011514) | 1.89346308 |
| 136 | Diplopia (HP:0000651) | 1.89346308 |
| 137 | Hyperparathyroidism (HP:0000843) | 1.88897774 |
| 138 | Abnormality of the pons (HP:0007361) | 1.87659834 |
| 139 | Sensorimotor neuropathy (HP:0007141) | 1.86231190 |
| 140 | Fair hair (HP:0002286) | 1.85998205 |
| 141 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.85899614 |
| 142 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.85863577 |
| 143 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.85863577 |
| 144 | Short hallux (HP:0010109) | 1.84910193 |
| 145 | Paraparesis (HP:0002385) | 1.84494663 |
| 146 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.83053633 |
| 147 | Congenital primary aphakia (HP:0007707) | 1.83015080 |
| 148 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.81869384 |
| 149 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.81869384 |
| 150 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.81869384 |
| 151 | Hemiplegia (HP:0002301) | 1.81830559 |
| 152 | Hypoplasia of the pons (HP:0012110) | 1.81519512 |
| 153 | Flat capital femoral epiphysis (HP:0003370) | 1.81313484 |
| 154 | Retinal dysplasia (HP:0007973) | 1.81229025 |
| 155 | CNS hypomyelination (HP:0003429) | 1.80900927 |
| 156 | Epiphyseal stippling (HP:0010655) | 1.80767033 |
| 157 | Irregular epiphyses (HP:0010582) | 1.79980953 |
| 158 | Abnormal ciliary motility (HP:0012262) | 1.79913591 |
| 159 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.79910697 |
| 160 | Bulbous nose (HP:0000414) | 1.79754281 |
| 161 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.79667146 |
| 162 | Drooling (HP:0002307) | 1.79286081 |
| 163 | Hyperglycinemia (HP:0002154) | 1.79142091 |
| 164 | Abnormal urine output (HP:0012590) | 1.77630430 |
| 165 | Small epiphyses (HP:0010585) | 1.76669351 |
| 166 | Insulin resistance (HP:0000855) | 1.76334429 |
| 167 | Ulnar claw (HP:0001178) | 1.76225655 |
| 168 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.76102911 |
| 169 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.75989438 |
| 170 | Abnormality of the vertebral endplates (HP:0005106) | 1.75661598 |
| 171 | Protuberant abdomen (HP:0001538) | 1.75472126 |
| 172 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.74851862 |
| 173 | Status epilepticus (HP:0002133) | 1.74830479 |
| 174 | Abnormality of chloride homeostasis (HP:0011422) | 1.74419771 |
| 175 | Abnormality of the fovea (HP:0000493) | 1.73693233 |
| 176 | Exocrine pancreatic insufficiency (HP:0001738) | 1.73690161 |
| 177 | Abnormality of purine metabolism (HP:0004352) | 1.73218390 |
| 178 | Arterial tortuosity (HP:0005116) | 1.72802558 |
| 179 | Abnormality of renin-angiotensin system (HP:0000847) | 1.72686699 |
| 180 | Generalized tonic-clonic seizures (HP:0002069) | 1.72639554 |
| 181 | Disproportionate short-trunk short stature (HP:0003521) | 1.72488793 |
| 182 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.72299810 |
| 183 | Xanthomatosis (HP:0000991) | 1.72267425 |
| 184 | Oligodactyly (hands) (HP:0001180) | 1.72151734 |
| 185 | Delusions (HP:0000746) | 1.72084290 |
| 186 | Macroglossia (HP:0000158) | 1.71603371 |
| 187 | Tetany (HP:0001281) | 1.71395414 |
| 188 | Small hand (HP:0200055) | 1.70760791 |
| 189 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.70548711 |
| 190 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.70548711 |
| 191 | Menstrual irregularities (HP:0000858) | 1.70472712 |
| 192 | Hyperglycinuria (HP:0003108) | 1.70448169 |
| 193 | Impaired smooth pursuit (HP:0007772) | 1.70381741 |
| 194 | Vascular tortuosity (HP:0004948) | 1.70156696 |
| 195 | Restlessness (HP:0000711) | 1.69768105 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPK15 | 3.54167710 |
| 2 | ARAF | 3.36252396 |
| 3 | TLK1 | 3.12186385 |
| 4 | ADRBK2 | 3.05166767 |
| 5 | MAPKAPK3 | 3.01274500 |
| 6 | STK39 | 2.77513591 |
| 7 | MST4 | 2.49621888 |
| 8 | GRK1 | 2.30488683 |
| 9 | WNK4 | 2.28867552 |
| 10 | FRK | 2.28708447 |
| 11 | CASK | 2.26467381 |
| 12 | NTRK3 | 2.15413427 |
| 13 | EIF2AK3 | 2.12713864 |
| 14 | OXSR1 | 2.12407478 |
| 15 | BCKDK | 2.05853980 |
| 16 | DAPK2 | 2.00300868 |
| 17 | MAP3K13 | 1.98937274 |
| 18 | MAPK13 | 1.98613591 |
| 19 | INSRR | 1.92886230 |
| 20 | MARK1 | 1.92518142 |
| 21 | MET | 1.92432158 |
| 22 | KSR2 | 1.88335551 |
| 23 | BRSK2 | 1.81204364 |
| 24 | TAOK3 | 1.79806325 |
| 25 | ZAK | 1.78999589 |
| 26 | MAP3K4 | 1.72137813 |
| 27 | SCYL2 | 1.67170598 |
| 28 | NTRK1 | 1.60249439 |
| 29 | RAF1 | 1.56714698 |
| 30 | STK38L | 1.55141789 |
| 31 | MAPKAPK5 | 1.52945860 |
| 32 | NEK6 | 1.51808149 |
| 33 | NTRK2 | 1.51792421 |
| 34 | MUSK | 1.51714425 |
| 35 | ERBB4 | 1.47408516 |
| 36 | IRAK3 | 1.38912811 |
| 37 | TESK2 | 1.38311809 |
| 38 | MAP2K7 | 1.37987944 |
| 39 | ADRBK1 | 1.34867607 |
| 40 | CAMKK2 | 1.34467763 |
| 41 | MOS | 1.32350009 |
| 42 | BRAF | 1.31902282 |
| 43 | BCR | 1.31661884 |
| 44 | NME2 | 1.31456720 |
| 45 | ACVR1B | 1.30169383 |
| 46 | NLK | 1.27977193 |
| 47 | FLT3 | 1.26920192 |
| 48 | EPHA3 | 1.26766057 |
| 49 | AKT3 | 1.26148533 |
| 50 | PINK1 | 1.24853751 |
| 51 | MAP4K2 | 1.19169139 |
| 52 | HIPK2 | 1.16820679 |
| 53 | PRKCG | 1.15663758 |
| 54 | MAP3K2 | 1.14683728 |
| 55 | SGK2 | 1.13473016 |
| 56 | PIK3CG | 1.13272937 |
| 57 | PHKG2 | 1.12424546 |
| 58 | PHKG1 | 1.12424546 |
| 59 | LIMK1 | 1.12173814 |
| 60 | SGK223 | 1.11176694 |
| 61 | SGK494 | 1.11176694 |
| 62 | MAP2K4 | 1.09756955 |
| 63 | ERN1 | 1.07925936 |
| 64 | TRPM7 | 1.07667862 |
| 65 | PIK3CA | 1.07560743 |
| 66 | PBK | 1.03181563 |
| 67 | FER | 1.02914047 |
| 68 | IRAK1 | 1.01042742 |
| 69 | MAP3K12 | 0.99640726 |
| 70 | EPHB1 | 0.96909803 |
| 71 | DYRK3 | 0.95629204 |
| 72 | EIF2AK1 | 0.93086894 |
| 73 | TEC | 0.92977742 |
| 74 | STK11 | 0.89961716 |
| 75 | CAMK2A | 0.89366768 |
| 76 | PTK2B | 0.88385866 |
| 77 | CAMK1 | 0.87682616 |
| 78 | PASK | 0.87140590 |
| 79 | ZAP70 | 0.85422311 |
| 80 | KDR | 0.84294884 |
| 81 | LATS1 | 0.82544113 |
| 82 | PAK3 | 0.82529709 |
| 83 | PNCK | 0.82479145 |
| 84 | CDK19 | 0.81955355 |
| 85 | NEK9 | 0.81617630 |
| 86 | WNK3 | 0.80923346 |
| 87 | PLK2 | 0.80833159 |
| 88 | BUB1 | 0.79677526 |
| 89 | JAK2 | 0.78894076 |
| 90 | EPHA4 | 0.77894318 |
| 91 | MAP3K1 | 0.77600787 |
| 92 | TGFBR1 | 0.77329570 |
| 93 | TNIK | 0.76275252 |
| 94 | CAMKK1 | 0.75756088 |
| 95 | OBSCN | 0.74581330 |
| 96 | NUAK1 | 0.74191244 |
| 97 | MKNK2 | 0.73824987 |
| 98 | STK3 | 0.72641058 |
| 99 | PKN1 | 0.72469015 |
| 100 | PRKCE | 0.72446732 |
| 101 | PIM2 | 0.69191196 |
| 102 | RPS6KA6 | 0.69085426 |
| 103 | GRK5 | 0.67944112 |
| 104 | JAK3 | 0.67355237 |
| 105 | FGFR2 | 0.65752275 |
| 106 | CAMK1D | 0.65248454 |
| 107 | CAMK2B | 0.64782867 |
| 108 | MARK3 | 0.64723925 |
| 109 | STK16 | 0.64340028 |
| 110 | ABL2 | 0.62388217 |
| 111 | MAP3K9 | 0.61971938 |
| 112 | TYK2 | 0.61261945 |
| 113 | CSNK1G1 | 0.59748913 |
| 114 | PRKD2 | 0.59028011 |
| 115 | SGK1 | 0.58868748 |
| 116 | BMPR1B | 0.58827229 |
| 117 | MAP2K1 | 0.58210112 |
| 118 | SIK2 | 0.58138037 |
| 119 | PRKCZ | 0.57642000 |
| 120 | WNK1 | 0.57466674 |
| 121 | CSNK1A1L | 0.56919954 |
| 122 | MAP2K6 | 0.56750565 |
| 123 | PRKACA | 0.56724195 |
| 124 | BLK | 0.55516647 |
| 125 | PRKAA1 | 0.54594340 |
| 126 | VRK1 | 0.54197793 |
| 127 | CAMK4 | 0.53619607 |
| 128 | CSNK1A1 | 0.52983911 |
| 129 | PRKCQ | 0.52822547 |
| 130 | CSNK1G3 | 0.52739538 |
| 131 | ITK | 0.52585328 |
| 132 | CSNK1G2 | 0.52518549 |
| 133 | ERBB2 | 0.52252838 |
| 134 | TBK1 | 0.51738065 |
| 135 | CDK5 | 0.51336285 |
| 136 | IRAK4 | 0.50516032 |
| 137 | GRK7 | 0.50166826 |
| 138 | NEK2 | 0.49451522 |
| 139 | PRKAA2 | 0.49210688 |
| 140 | CHUK | 0.47149844 |
| 141 | MAP2K2 | 0.47051520 |
| 142 | PAK6 | 0.45744062 |
| 143 | STK24 | 0.45696013 |
| 144 | CAMK2G | 0.45157178 |
| 145 | PTK2 | 0.44905624 |
| 146 | RPS6KA5 | 0.44726944 |
| 147 | CAMK2D | 0.44642628 |
| 148 | CAMK1G | 0.44380716 |
| 149 | DYRK2 | 0.43921795 |
| 150 | FGR | 0.43789047 |
| 151 | TIE1 | 0.43251931 |
| 152 | STK38 | 0.42643552 |
| 153 | TESK1 | 0.42157917 |
| 154 | STK10 | 0.40891480 |
| 155 | SGK3 | 0.40763444 |
| 156 | FGFR4 | 0.40596677 |
| 157 | TYRO3 | 0.39683355 |
| 158 | CSK | 0.39534027 |
| 159 | PRKCI | 0.39386051 |
| 160 | IKBKE | 0.38865142 |
| 161 | CSNK1D | 0.38307986 |
| 162 | DYRK1B | 0.37996585 |
| 163 | MARK2 | 0.37926737 |
| 164 | PDPK1 | 0.37729110 |
| 165 | PRKCH | 0.37719678 |
| 166 | IKBKB | 0.37594940 |
| 167 | PRKCA | 0.37298951 |
| 168 | MAP3K7 | 0.37256487 |
| 169 | DYRK1A | 0.36909831 |
| 170 | RPS6KA3 | 0.36534102 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protein export_Homo sapiens_hsa03060 | 5.81040635 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 5.10211188 |
| 3 | Sulfur metabolism_Homo sapiens_hsa00920 | 4.14223901 |
| 4 | Nicotine addiction_Homo sapiens_hsa05033 | 3.34970153 |
| 5 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.80198345 |
| 6 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.66664735 |
| 7 | Phototransduction_Homo sapiens_hsa04744 | 2.52256407 |
| 8 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.33147715 |
| 9 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.31708447 |
| 10 | Lysosome_Homo sapiens_hsa04142 | 2.31634100 |
| 11 | Regulation of autophagy_Homo sapiens_hsa04140 | 2.31267044 |
| 12 | Morphine addiction_Homo sapiens_hsa05032 | 2.25195742 |
| 13 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.24421304 |
| 14 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.18162713 |
| 15 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.15837951 |
| 16 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.00739130 |
| 17 | Circadian entrainment_Homo sapiens_hsa04713 | 1.94946312 |
| 18 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.89559650 |
| 19 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.87102556 |
| 20 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.86068133 |
| 21 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.81076508 |
| 22 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.80123337 |
| 23 | GABAergic synapse_Homo sapiens_hsa04727 | 1.76581496 |
| 24 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.72413943 |
| 25 | Taste transduction_Homo sapiens_hsa04742 | 1.72362974 |
| 26 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.64716577 |
| 27 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.56976708 |
| 28 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.49341303 |
| 29 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.46749179 |
| 30 | Other glycan degradation_Homo sapiens_hsa00511 | 1.45472709 |
| 31 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.39513744 |
| 32 | Olfactory transduction_Homo sapiens_hsa04740 | 1.38691003 |
| 33 | Salivary secretion_Homo sapiens_hsa04970 | 1.36540907 |
| 34 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.36477068 |
| 35 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.36050949 |
| 36 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.35063815 |
| 37 | Cocaine addiction_Homo sapiens_hsa05030 | 1.34492802 |
| 38 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.33258039 |
| 39 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.32698099 |
| 40 | Histidine metabolism_Homo sapiens_hsa00340 | 1.29616949 |
| 41 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.29059857 |
| 42 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.28225894 |
| 43 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.26139676 |
| 44 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.22153690 |
| 45 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.19303435 |
| 46 | Peroxisome_Homo sapiens_hsa04146 | 1.17555781 |
| 47 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.14828109 |
| 48 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.12514501 |
| 49 | RNA polymerase_Homo sapiens_hsa03020 | 1.10859382 |
| 50 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.10115562 |
| 51 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.07828719 |
| 52 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.07219660 |
| 53 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.05251657 |
| 54 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.04468514 |
| 55 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.99347577 |
| 56 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.98920610 |
| 57 | Proteasome_Homo sapiens_hsa03050 | 0.98722820 |
| 58 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.98213749 |
| 59 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.96870152 |
| 60 | Parkinsons disease_Homo sapiens_hsa05012 | 0.96242295 |
| 61 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.95590850 |
| 62 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.93442541 |
| 63 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.91874253 |
| 64 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.91562135 |
| 65 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.90264034 |
| 66 | Alzheimers disease_Homo sapiens_hsa05010 | 0.90243447 |
| 67 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.90070856 |
| 68 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.88813006 |
| 69 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.88570019 |
| 70 | Circadian rhythm_Homo sapiens_hsa04710 | 0.88499343 |
| 71 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.88376898 |
| 72 | Long-term depression_Homo sapiens_hsa04730 | 0.88288716 |
| 73 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.88170772 |
| 74 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.87682506 |
| 75 | Renin secretion_Homo sapiens_hsa04924 | 0.85285662 |
| 76 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.84093213 |
| 77 | Phagosome_Homo sapiens_hsa04145 | 0.82993780 |
| 78 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.81125538 |
| 79 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.80799581 |
| 80 | Homologous recombination_Homo sapiens_hsa03440 | 0.80744395 |
| 81 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.80172498 |
| 82 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.78431194 |
| 83 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.77940857 |
| 84 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.77112245 |
| 85 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.76568964 |
| 86 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.76456847 |
| 87 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.76085080 |
| 88 | Retinol metabolism_Homo sapiens_hsa00830 | 0.75943318 |
| 89 | Metabolic pathways_Homo sapiens_hsa01100 | 0.74522140 |
| 90 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.73730269 |
| 91 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.66734389 |
| 92 | Insulin secretion_Homo sapiens_hsa04911 | 0.65296609 |
| 93 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64311704 |
| 94 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.62111897 |
| 95 | Prion diseases_Homo sapiens_hsa05020 | 0.61156942 |
| 96 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.60439060 |
| 97 | Axon guidance_Homo sapiens_hsa04360 | 0.60270856 |
| 98 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.59276821 |
| 99 | Huntingtons disease_Homo sapiens_hsa05016 | 0.58971923 |
| 100 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.58174516 |
| 101 | Mineral absorption_Homo sapiens_hsa04978 | 0.54529214 |
| 102 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.54027307 |
| 103 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.53849878 |
| 104 | Endocytosis_Homo sapiens_hsa04144 | 0.53779273 |
| 105 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.53235701 |
| 106 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.51780146 |
| 107 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.51619585 |
| 108 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.51408070 |
| 109 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.51117366 |
| 110 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.50429278 |
| 111 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.50196427 |
| 112 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.49339135 |
| 113 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.47943596 |
| 114 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.47913368 |
| 115 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.47131980 |
| 116 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46103302 |
| 117 | Bile secretion_Homo sapiens_hsa04976 | 0.45394803 |
| 118 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.45155474 |
| 119 | Alcoholism_Homo sapiens_hsa05034 | 0.43035348 |
| 120 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.41885452 |
| 121 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.41110110 |
| 122 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.40750724 |
| 123 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.39728726 |
| 124 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.39646977 |
| 125 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39352316 |
| 126 | Basal transcription factors_Homo sapiens_hsa03022 | 0.38872182 |
| 127 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.38822417 |
| 128 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.37286233 |
| 129 | Sulfur relay system_Homo sapiens_hsa04122 | 0.36318161 |
| 130 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.35323373 |
| 131 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.35008375 |
| 132 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.33977472 |
| 133 | Malaria_Homo sapiens_hsa05144 | 0.31912544 |
| 134 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.31900898 |
| 135 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.31131578 |
| 136 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.30722118 |
| 137 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.30055892 |
| 138 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.29491201 |
| 139 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.29353512 |
| 140 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.29100455 |
| 141 | Shigellosis_Homo sapiens_hsa05131 | 0.29089129 |
| 142 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.27871012 |
| 143 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.27163531 |
| 144 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.24084946 |
| 145 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.21746774 |
| 146 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.21663065 |
| 147 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.20114649 |
| 148 | ABC transporters_Homo sapiens_hsa02010 | 0.18604435 |
| 149 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.16902558 |
| 150 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.12754416 |
| 151 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.11611439 |
| 152 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.11089435 |

